Mablink Bioscience appoints Pejvack Motlagh, M.D., as Chief Medical Officer
Mablink Bioscience appoints Pejvack Motlagh, M.D., as Chief Medical Officer
Source: smdailyjournal.com
Page 3 - Mablink Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mablink Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mablink Bioscience Today - Breaking & Trending Today
Samsung Ventures invests in Araris Biotech in emerging ADC strategy
Samsung Ventures, the global investment arm of Samsung Group, has invested an undisclosed amount in the Swiss company Araris Biotech. The deal is independent from Araris’ ongoing Series A fundraising and will be used to bankroll the development of antibody-drug conjugates for cancer.
Source: biopharma-reporter.com
Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners | Antibodies
Mablink Bioscience announces a €31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
Source: pipelinereview.com
Investegate |Mablink Bioscience Announcements | Mablink Bioscience: Mablink Bioscience announces a 31 million Series A
Investegate announcements from Mablink Bioscience, Mablink Bioscience announces a 31 million Series A
Source: investegate.co.uk
Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners
The financing will enable the company to advance its lead candidate to the clinic and to build a pipeline of next-generation antibody-drug conjugates (ADCs)Its proprietary ADC technology opens the door
Source: finanznachrichten.de